
SciBase Secures SEK 57.5 Million in Fully Subscribed Rights Issue
Stockholm-based medical technology firm SciBase has successfully closed its rights issue, raising approximately SEK 57.5 million to bolster its expansion into the U.S. market. The capital injection comes as the company navigates a critical phase in securing reimbursement for its AI-driven skin diagnostic platform, Nevisense.





















